Arise Online Quiz - North Zone - Nov'17

20 Questions | By Anaysisoudia | Last updated: Mar 21, 2022 | Total Attempts: 167

Questions

Settings

Create your own Quiz

Questions and Answers

1.

The DDSI technology in Swich Tablet ensures-the particle size of Cefpodoxime less than 10 micron. This leads to:
- A.
  
  Faster Dissolution
- B.
  
  Faster Absorption
- C.
  
  Faster Onset of Action
- D.
  
  None of the Above
2.

The DDSI technology in Swich Tablet offers unique hydrophilic polymer of Cefpodoxime. This leads to:
- A.
  
  Faster Dissolution
- B.
  
  Faster Absorption
- C.
  
  Faster Onset of Action
- D.
  
  None of the Above
3.

The DDSI technology in Swich Tablet ensures 90% dissolution in 30 minutes of Cefpodoxime. This leads to:
- A.
  
  Faster Dissolution
- B.
  
  Faster Absorption
- C.
  
  Faster Onset of Action
- D.
  
  None of the Above
4.

The dosage of Swich DS is
- A.
  
  20 mg/kg/day as a single dose
- B.
  
  10 mg/kg/day in 2 divided dosage
- C.
  
  20 mg/kg/day in 2 divided dose
- D.
  
  10 mg/kg/day as a single dose
5.

The dissolution of Swich DT takes place within
- A.
  
  30 minutes
- B.
  
  20 minutes
- C.
  
  20 seconds
- D.
  
  30 seconds
6.

Swich drops can be used up to .................. after reconstitution.
- A.
  
  10 days
- B.
  
  7 days
- C.
  
  15 days
- D.
  
  20 days
7.

The stability of Swich CV Tablet during formulation is ensured by Nitrogen Flushing
- A.
  
  True
- B.
  
  False
8.

The stability of Swich CV Tablet post formulation is ensured by Cold Press Stripping
- A.
  
  True
- B.
  
  False
9.

The shelf life of Swich CV Tablet is
- A.
  
  18 months
- B.
  
  22 months
- C.
  
  24 months
- D.
  
  26 months
10.

The Amber Colour Glass bottle of Swich CV DS ensures UV protection
- A.
  
  True
- B.
  
  False
11.

The Nitrogen Flushed packing of Swich CV DS ensures moisture protection
- A.
  
  True
- B.
  
  False
12.

Rifakem improves IBS symptom
- A.
  
  Up to 15 weeks after discontinuation of therapy
- B.
  
  Up to 8 weeks after discontinuation of therapy
- C.
  
  Up to 20 weeks after discontinuation of therapy
- D.
  
  Up to 10 weeks after discontinuation of therapy
13.

Rifakem offers
- A.
  
  Lower Glucose Breath normalization rate & decontamination rate
- B.
  
  Higher Glucose Breath normalization rate & contamination rate
- C.
  
  Higher Glucose Breath normalization rate & decontamination rate
- D.
  
  Lower Glucose Breath normalization rate & contamination rate
14.

Esokem-40 mg maintains intra-gastric pH
- A.
  
  Above 4 for 12.8 hrs: 6 hrs more than any other PPI
- B.
  
  Above 4 for 16.8 hrs: 4 hrs more than any other PPI
- C.
  
  Above 4 for 16.8 hrs: 6 hrs more than any other PPI
- D.
  
  Above 4 for 14.8 hrs: 4 hrs more than any other PPI
15.

Select the right dose of Rifakem in Infectious diarrhoea?
- A.
  
  Rifakem 400mg TID for 14 day’s
- B.
  
  Rifakem 200mg TID for 3 day’s
- C.
  
  Rifakem 400 mg TID for 3 day’s
- D.
  
  Rifakem 550 mg TID for 14 day’s
16.

Packing advantage of Low Density Polyethylene in Novogermina ensures
- A.
  
  Novogermina can sustain a temperature of 50 degree Celsius
- B.
  
  Novogermina can sustain a temperature of 45 degree Celsius
- C.
  
  Novogermina can sustain a temperature of 110 degree Celsius
- D.
  
  Novogermina can sustain a temperature of 55 degree Celsius
17.

Novogermina contains original Bacillus Clausii strain
- A.
  
  UBBC 05
- B.
  
  UBBC 01
- C.
  
  UBBC 07
- D.
  
  UBBC 02
18.

Albendazole+Ivermectin in Noworm-Plus ensures ………………..% egg reduction rate
- A.
  
  94.5%
- B.
  
  99%
- C.
  
  89%
- D.
  
  94%
19.

Novogermina contains 2 Billion spores of bacillus Clausii in .......ml oral suspension
- A.
  
  5 ml
- B.
  
  1 ml
- C.
  
  10 ml
- D.
  
  2 ml
20.

In Swich XP
- A.
  
  Tazobactum reduces MIC of ceftriaxone from 256mcg/ml to 2-4mcg/ml
- B.
  
  Tazobactum reduces MIC of ceftriaxone from 246mcg/ml to 2-4mg/ml
- C.
  
  Tazobactum reduces MIC of ceftriaxone from 256mcg/ml to 4-6mcg/ml
- D.
  
  Tazobactum reduces MIC of ceftriaxone from 256mcg/ml to 6-8 mcg/ml